Samsung Biologics
KOSPI · Healthcare · ₩65T
₩1,389,000-4.34%
Price
1,379,000원
1,388,983원
Jul 23, 26Oct 27, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue₩1.5T+12.8%
Operating Income₩640.1B+9.1%
Net Income₩391.1B-9.2%
6/'26 vs prev quarter
Company Health
Market Cap₩65T
Operating Margin+49.9%
Free Cash Flow1.1조원1.7% of market cap
Short Volume 15.3% · as of 26.10.26
Among 34 바이오 peers
LowMedianHigh
PSR14.4xmedian 5.6xPER35.0xmedian 16.9x
